3 курс / Фармакология / Лекарственные_средства,_применяемые_в_акушерстве_и_гинекологии,
.pdfɁɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
|
ɉɟɧɬɨɤɫɢɮɢɥɥɢɧ |
0,4 ɝ |
0,8 ɝ |
ɜɧɭɬɪɶ |
5 ɫɭɬ |
|
|
|
(«Ⱥɝɚɩɭɪɢɧ ɪɟɬɚɪɞ») |
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
Ⱥɰɟɬɢɥɫɚɥɢɰɢɥɨɜɚɹ ɤɢ- |
0,05–0,1 ɝ |
0,05–0,1 ɝ |
ɜɧɭɬɪɶ |
5 ɫɭɬ |
|
|
|
ɫɥɨɬɚ («Ɍɪɨɦɛɨ Ⱥɋɋ») |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ɗɍȻɂɈɌɂɄɂ |
|
|
|
|
|
|
Ȼɢɮɢɞɭɦɛɚɤɬɟɪɢɢ, ɥɢɨɮɢɥɢɡɢɪɨɜɚɧɧɵɟ ɛɚɤɬɟɪɢɢ Lactobacillus acidophilus, Bifidobacterium |
|
|||||
|
infantis v.liberorum, Streptococcus faecium ɢ ɞɪ. |
|
|
|
|||
|
|
Ȼɢɮɢɞɨɛɚɤɬɟɪɢɢ ɛɢɮɢ- |
5 ɞɨɡ |
15 ɞɨɡ |
ɜɧɭɬɪɶ |
10–12 ɫɭɬ |
|
|
|
ɞɭɦ |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
«Ȼɢɮɢɞɨɛɚɤɬɟɪɢɧ |
2 ɞɨɡɵ |
6 ɞɨɡ |
ɜɧɭɬɪɶ |
10–12 ɫɭɬ |
|
|
|
ɮɨɪɬɟ» |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
«ɏɢɥɚɤ ɮɨɪɬɟ» |
5 ɦɥ |
15–20 ɦɥ |
ɜɧɭɬɪɶ |
10–12 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
«Ʌɢɧɟɤɫ» |
1 ɤɚɩɫɭɥɚ |
3 ɤɚɩɫɭɥɵ |
ɜɧɭɬɪɶ |
10–12 ɫɭɬ |
|
|
|
|
|
|
|
|
|
|
ɉɊɂ ɌəɀȿɅɕɏ ɎɈɊɆȺɏ ɗɇȾɈɆȿɌɊɂɌȺ |
|
|
|
|||
|
ɉɥɚɡɦɚɮɟɪɟɡ |
|
|
|
|
|
|
|
|
|
|
|
|
||
|
Ⱦɥɹ ɟɝɨ ɨɛɟɫɩɟɱɟɧɢɹ — ɩɥɚɡɦɨɡɚɦɟɧɢɬɟɥɢ: |
|
|
|
|
||
|
|
Ȼɟɥɤɨɜɵɟ |
|
|
|
|
|
|
|
Ⱥɥɶɛɭɦɢɧ 10% ɪ-ɪ |
100 ɦɥ |
100–200 ɦɥ |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
2–3 ɫɭɬ |
|
|
|
Ʉɨɥɥɨɢɞɵ: |
|
|
|
|
|
|
|
Ƚɢɞɪɨɤɫɢɷɬɢɥɤɪɚɯɦɚɥ |
250–500 ɦɥ |
500 ɦɥ |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
2–3 ɫɭɬ |
|
|
|
6–10% ɪ-ɪ («Ɋɟɮɨɪɬɚɧ |
|
|
|
|
|
|
|
ȽɗɄ») |
|
|
|
|
|
|
|
|
|
|
|
|
|
162
6 Раздел
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ⱦɟɤɫɬɪɚɧ [ɫɪɟɞɧɹɹ ɦɨ- |
400 ɦɥ |
400 ɦɥ |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
2–3 ɫɭɬ |
|
|
|
ɥɟɤɭɥɹɪɧɚɹ ɦɚɫɫɚ |
|
|
|
|
|
|
|
30 000–40 000] («Ɋɟɨ- |
|
|
|
|
|
|
|
ɩɨɥɢɝɥɸɤɢɧ») ɪ-ɪ |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɉɨɜɢɞɨɧ 8000+ɧɚɬɪɢɹ |
200–400 ɦɥ |
200–400 |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
2–3 ɫɭɬ |
|
|
|
ɯɥɨɪɢɞ+ɤɚɥɢɹ ɯɥɨ- |
|
ɦɥ |
|
|
|
|
|
ɪɢɞ+ɤɚɥɶɰɢɹ ɯɥɨ- |
|
|
|
|
|
|
|
ɪɢɞ+ɦɚɝɧɢɹ ɯɥɨ- |
|
|
|
|
|
|
|
ɪɢɞ+ɧɚɬɪɢɹ ɝɢɞɪɨɤɚɪ- |
|
|
|
|
|
|
|
ɛɨɧɚɬ («Ƚɟɦɨɞɟɡ-ɇ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ⱦɟɤɫɬɪɚɧ [ɫɪɟɞɧɹɹ ɦɨ- |
400 ɦɥ |
400 ɦɥ |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
2–3 ɫɭɬ |
|
|
|
ɥɟɤɭɥɹɪɧɚɹ ɦɚɫɫɚ |
|
|
|
|
|
|
|
50 000–70 000] («ɉɨɥɢ- |
|
|
|
|
|
|
|
ɝɥɸɤɢɧ») ɪ-ɪ |
|
|
|
|
|
|
|
Ʉɪɢɫɬɚɥɥɨɢɞɵ: |
|
|
|
|
|
|
|
ɇɚɬɪɢɹ ɯɥɨɪɢɞ |
400 ɦɥ |
400 ɦɥ |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
2–3 ɫɭɬ |
|
|
|
0,9% ɪ-ɪ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ⱥɧɬɢɤɨɚɝɭɥɹɧɬɵ: |
|
|
|
|
|
|
|
Ƚɟɩɚɪɢɧ ɧɚɬɪɢɹ |
5000–7500 ȿȾ |
5000–7500 |
ɜ/ɜ |
3–5 ɫɭɬ |
|
|
|
|
|
ȿȾ |
|
|
|
|
|
|
|
|
|
|
|
|
|
ȺɇȿɋɌȿɁɂɈɅɈȽɂɑȿɋɄɈȿ |
ɉɈɋɈȻɂȿ |
ɉɊɂ ɆȺɅɕɏ ɈɉȿɊȺɐɂəɏ |
ȼɚɤɭɭɦ-ɚɫɩɢɪɚɰɢɹ, |
||
|
ȼɧɭɬɪɢɜɟɧɧɵɣ ɧɚɪɤɨɡ |
|
|
|
|
ɜɵɫɤɚɛɥɢɜɚɧɢɟ ɦɚɬɤɢ |
|
|
|
|
|
|
|
|
|
|
|
Ʉɟɬɚɦɢɧ |
|
2–4,5 ɦɝ/ɤɝ |
ɜ/ɜ |
Ɉɞɧɨɤɪɚɬɧɨ ɜɨ |
|
163 ...заболеваний инфекционных терапии при применяемые ЛС,
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
ɜɪɟɦɹ ɧɚɪɤɨɡɚ |
|
|
|
ɉɪɨɩɨɮɨɥ («Ⱦɢɩɪɢ- |
|
1,5–2,5 |
ɜ/ɜ |
|
|
|
|
ɜɚɧ») |
|
ɦɝ/ɤɝ |
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ɍɢɨɩɟɧɬɚɥ ɧɚɬɪɢɹ |
|
3–10 ɦɝ/ɤɝ |
ɜ/ɜ |
|
|
Ɉ85 ɋɟɩɬɢɰɟɦɢɹ, |
|
Ⱥ. ȺɇɌɂȻɂɈɌɂɄɂ. |
|
|
|
|
Ɉɫɧɨɜɧɵɟ ɩɪɢɧɰɢɩɵ |
ɋɟɩɬɢɤɨɩɢɟɦɢɹ |
|
I. Ɇɨɧɨɬɟɪɚɩɢɹ |
|
|
|
|
ɬɟɪɚɩɢɢ ɚɤɭɲɟɪɫɤɨɝɨ |
Ⱥɫɫɨɰɢɚɰɢɢ |
|
|
|
|
|
||
ɚɷɪɨɛɧɵɯ ɢ ɚɧɚ- |
|
ɐɟɮɨɩɟɪɚ- |
2 ɝ |
4–8 ɝ |
ɜ/ɜ, ɜ/ɦ |
10–12 ɫɭɬ |
ɫɟɩɫɢɫɚ: |
|
ɡɨɧ+ɫɭɥɶɛɚɤɬɚɦ |
|
|
|
|
1. ɋɚɧɚɰɢɹ ɩɟɪɜɢɱɧɨ- |
|
ɷɪɨɛɧɵɯ ɦɢɤɪɨ- |
|
|
|
|
|
||
ɨɪɝɚɧɢɡɦɨɜ: |
|
(«ɋɭɥɶɩɟɪɚɡɨɧ») |
|
|
|
|
ɝɨ ɨɱɚɝɚ ɢɧɮɟɤɰɢɢ: |
E. сoli, Proteus |
|
ɢɥɢ |
|
|
|
|
— ɜɚɤɭɭɦ-ɚɫɩɢɪɚɰɢɹ; |
spp., Klebsiella |
|
ɐɟɮɟɩɢɦ («Ɇɚɤɫɢ- |
1–2 ɝ |
2–4 ɝ |
ɜ/ɜ, ɜ/ɦ |
10–12 ɫɭɬ |
— ɜɵɫɤɚɛɥɢɜɚɧɢɟ |
spp., |
|
||||||
|
ɩɢɦ») |
|
|
|
|
ɫɬɟɧɨɤ ɩɨɫɥɟ ɪɨɞɨɜɨɣ |
|
Enterobacter |
|
|
|
|
|
||
|
ɢɥɢ |
|
|
|
|
ɦɚɬɤɢ; |
|
spp., |
|
|
|
|
|
||
Enterococcus |
|
ɂɦɢɩɟɧɟɦ+ɰɢɥɚɫɬɚɬɢɧ |
1 ɝ |
2–4 ɝ |
ɜ/ɜ |
10–12 ɫɭɬ |
— ɷɤɫɬɢɪɩɚɰɢɹ ɦɚɬɤɢ |
spp., Bacteroides |
|
(«Ɍɢɟɧɚɦ») |
|
|
|
|
ɩɪɢ ɩɟɪɢɬɨɧɢɬɟ ɩɨɫɥɟ |
spp., |
|
ɢɥɢ |
|
|
|
|
Ʉɋ, ɧɟɤɪɨɬɢɱɟɫɤɨɦ |
Peptostrepto- |
|
|
|
|
|
||
|
Ɇɟɪɨɩɟɧɟɦ («Ɇɟɪɨ- |
0,5 ɝ |
1,5–3 ɝ |
ɜ/ɜ |
10–12 ɫɭɬ |
ɷɧɞɨɦɟɬɪɢɬɟ, ɩɪɢ ɩɨ- |
|
coccus spp., |
|
||||||
|
ɧɟɦ») |
|
|
|
|
ɱɟɱɧɨ-ɩɟɱɟɧɨɱɧɨɣ ɧɟ- |
|
cɬɪɟɩɬɨɤɨɤɤɢ |
|
|
|
|
|
||
ɝɪɭɩɩɵ ȼ., |
ɢɥɢ |
|
|
|
|
|
ɞɨɫɬɚɬɨɱɧɨɫɬɢ. |
Staphylococcus |
|
|
|
|
2. Ʉɨɦɩɥɟɤɫɧɚɹ ɬɟɪɚ- |
||
II. Ʉɨɦɛɢɧɢɪɨɜɚɧɧɚɹ ɬɟɪɚɩɢɹ |
|
|
|
||||
spp., |
|
|
|
|
|
|
ɩɢɹ: — ɫɦ. ɩɨ ɪɚɡɞɟ- |
|
ɐɟɮɨɬɚɤɫɢɦ («Ʉɥɚɮɨ- |
1–2 ɝ |
3–8 ɝ |
ɜ/ɜ, ɜ/ɦ |
10–12 ɫɭɬ |
||
Сhlamidia tra- |
|
||||||
|
ɪɚɧ») |
|
|
|
|
ɥɚɦ. |
|
chomatis, |
|
|
|
|
|
||
Mycoplasma |
|
ɢɥɢ |
|
|
|
|
|
hominis, |
|
ɐɟɮɬɚɡɢɞɢɦ («Ɏɨɪ- |
1–2 ɝ |
4–6 ɝ |
ɜ/ɜ, ɜ/ɦ |
10–12 ɫɭɬ |
|
Ureaplasma |
|
ɬɭɦ») |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
164
6 Раздел
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
urealyticum |
|
ɢɥɢ |
|
|
|
|
|
ɢ ɞɪ. |
|
ɐɟɮɨɩɟɪɚɡɨɧ («ɐɟɮɨ- |
1–2 ɝ |
2–4 ɝ |
ɜ/ɜ |
10–12 ɫɭɬ |
|
|
|
|
|||||
|
|
ɛɢɞ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɐɟɮɬɪɢɚɤɫɨɧ («Ɋɨɰɟ- |
1–2 ɝ |
2–4 ɝ |
ɜ/ɜ |
10–12 ɫɭɬ |
Ⱥɦɢɧɨɝɥɢɤɨɡɢɞɵ ɜɜɨ- |
|
|
ɮɢɧ», «ɐɟɮɬɪɢɚɛɨɥ») |
|
|
|
|
ɞɹɬɫɹ ɜ 1–2 ɜɜɟɞɟɧɢɹ |
|
|
|
|
|
|
|
|
|
+ |
|
|
|
|
|
|
|
|
Ƚɟɧɬɚɦɢɰɢɧ |
|
3–5 ɦɝ/ɤɝ |
ɜ/ɦ |
4–5 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
ɉɪɨɞɨɥɠɢɬɟɥɶɧɨɫɬɶ |
|
|
ɇɟɬɢɥɦɢɰɢɧ |
|
3–5 ɦɝ/ɤɝ |
ɜ/ɦ |
4–5 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
ɚɧɬɢɛɢɨɬɢɤɨɬɟɪɚɩɢɢ |
|
|
Ⱥɦɢɤɚɰɢɧ |
|
15–20 |
ɜ/ɦ |
4–5 ɫɭɬ |
ɡɚɜɢɫɢɬ ɨɬ ɬɹɠɟɫɬɢ |
|
|
|
|
ɦɝ/ɤɝ |
|
|
ɡɚɛɨɥɟɜɚɧɢɹ ɢ ɤɥɢɧɢ- |
|
|
|
|
|
|
|
ɱɟɫɤɨɣ ɷɮɮɟɤɬɢɜɧɨ- |
|
+ |
|
|
|
|
|
|
|
|
|
|
|
|
|
ɫɬɢ ɥɟɱɟɧɢɹ. Ɉɬɦɟ- |
|
|
Ʉɥɢɧɞɚɦɢɰɢɧ |
0,3–0,6 ɝ |
0,9–1,8 ɝ |
ɜ/ɜ, ɜ/ɦ |
10–12 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
ɧɹɬɶ ɚɧɬɢɛɢɨɬɢɤɢ |
|
|
Ʌɢɧɤɨɦɢɰɢɧ |
0,6 ɝ |
1,8 ɝ |
ɜ/ɜ, ɜ/ɦ |
10–12 ɫɭɬ |
ɦɨɠɧɨ ɱɟɪɟɡ 3–4 ɞɧɹ |
|
|
ɢɥɢ |
|
|
|
|
ɩɨɫɥɟ ɧɨɪɦɚɥɢɡɚɰɢɢ |
|
|
Ɇɟɬɪɨɧɢɞɚɡɨɥ |
0,5 ɝ |
1–1,5 ɝ |
ɜ/ɜ |
10–12 ɫɭɬ |
ɬɟɦɩɟɪɚɬɭɪɵ ɬɟɥɚ ɢ |
|
|
|
|
|
|
|
ɨɫɧɨɜɧɵɯ ɥɚɛɨɪɚɬɨɪ- |
|
ɢɥɢ |
|
|
|
|
|
|
|
|
|
|
|
|
|
ɧɵɯ ɩɨɤɚɡɚɬɟɥɟɣ |
|
|
Ⱥɦɨɤɫɢɰɢɥɥɢɧ+ɤɥɚɜɭ- |
1,2 ɝ |
3,6 ɝ |
ɜ/ɜ |
10–12 ɫɭɬ |
|
|
|
|
|||||
|
|
ɥɚɧɨɜɚɹɤɢɫɥɨɬɚ («Ⱥɦɨ- |
|
|
|
|
|
|
|
ɤɫɢɤɥɚɜ», «Ⱥɭɝɦɟɧɬɢɧ») |
|
|
|
|
|
|
+ |
|
|
|
|
|
|
|
|
Ⱥɦɢɤɚɰɢɧ |
0,1 ɝ |
15– |
ɜ/ɦ |
4–5 ɫɭɬ |
|
|
|
|
|
20 ɦɝ/ɤɝ/ɫ |
|
|
|
|
|
|
|
|
|
|
|
165 ...заболеваний инфекционных терапии при применяемые ЛС,
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
|
166 |
|
|
|
|||||||
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
|
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
|
Ƚɟɧɬɚɦɢɰɢɧ |
|
3–5 ɦɝ/ɤɝ/ɫ |
ɜ/ɦ |
4–5 ɫɭɬ |
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
|
ɇɟɬɢɥɦɢɰɢɧ |
|
3–5 ɦɝ/ɤɝ/ɫ |
ɜ/ɦ |
4–5 ɫɭɬ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
+ |
|
|
|
|
|
|
|
|
|
|
Ɇɟɬɪɨɧɢɞɚɡɨɥ |
0,5 ɝ |
1–1,5 ɝ |
ɜ/ɜ |
10–12 ɫɭɬ |
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
|
|
Ʌɟɜɨɮɥɨɤɫɚɰɢɧ («Ɍɚ- |
0,5 ɝ |
1 ɝ |
ɜ/ɜ |
10 ɫɭɬ ɢ ɛɨɥɟɟ |
|
|
|
|
|
ɜɚɧɢɤ») |
|
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
|
Ɉɮɥɨɤɫɚɰɢɧ («Ɍɚɪɢ- |
0,1–0,2 ɝ |
0,2–0,4 ɝ |
ɜ/ɜ |
10 ɫɭɬ ɢ ɛɨɥɟɟ |
|
|
|
|
|
ɜɢɞ») |
|
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
|
ɉɟɮɥɨɤɫɚɰɢɧ («Ⱥɛɚɤ- |
0,4 ɝ |
0,8 ɝ |
ɜ/ɜ |
10 ɫɭɬ ɢ ɛɨɥɟɟ |
|
|
|
|
|
ɬɚɥ») |
|
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
|
ɐɢɩɪɨɮɥɨɤɫɚɰɢɧ |
0,4 ɝ |
0,8 ɝ |
ɜ/ɜ |
10 ɫɭɬ ɢ ɛɨɥɟɟ |
|
|
|
|
|
(«Ʉɜɢɧɬɨɪ», «ɐɢɩɪɨ- |
|
|
|
|
|
|
|
|
|
ɛɚɣ», «ɐɢɩɪɨɥɟɬ») |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
+ |
|
|
|
|
|
|
|
|
|
|
Ɇɟɬɪɨɧɢɞɚɡɨɥ |
0,5 ɝ |
1–1,5 ɝ |
ɜ/ɜ |
10 ɫɭɬ ɢ ɛɨɥɟɟ |
|
|
|
ȼɨɡɛɭɞɢɬɟɥɶ |
|
Ɉɤɫɚɰɢɥɥɢɧ |
2–3 ɝ |
8–12 ɝ |
ɜ/ɜ |
10 ɢ ɛɨɥɟɟ ɫɭɬ |
|
|
Раздел |
S. aureus |
|
ɢɥɢ |
|
|
|
|
|
|
|
|
|
ɐɟɮɚɡɨɥɢɧ |
2 ɝ |
6 ɝ |
ɜ/ɜ |
10 ɢ ɛɨɥɟɟ ɫɭɬ |
|
|
|
|
+ |
|
|
|
|
|
|
|
6 |
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
|
Ɇɟɬɪɨɧɢɞɚɡɨɥ |
0,5 ɝ |
1,0–1,5 ɝ |
ɜ/ɜ |
10 ɢ ɛɨɥɟɟ ɫɭɬ |
|
ȼɨɡɛɭɞɢɬɟɥɶ — |
|
ȼɚɧɤɨɦɢɰɢɧ |
1 ɝ |
2 ɝ |
ɜ/ɜ |
10 ɢ ɛɨɥɟɟ ɫɭɬ |
|
ɦɟɬɢɰɢɥɥɢɧ- |
+ |
|
|
|
|
|
|
ɪɟɡɢɫɬɟɧɬɧɵɣ |
|
Ɇɟɬɪɨɧɢɞɚɡɨɥ |
0,5 ɝ |
1–1,5 ɝ |
ɜ/ɜ |
10 ɫɭɬ ɢ ɛɨɥɟɟ |
|
S. aureus |
|
|
|
|
|
|
|
|
|
ɉɊɈɎɂɅȺɄɌɂɄȺ ɄȺɇȾɂȾɈɁȺ |
|
|
|
|
|
|
|
Ɏɥɭɤɨɧɚɡɨɥ («Ⱦɢɮɥɸ- |
0,1 ɝ |
0,1 ɝ |
ɜ/ɜ |
1 ɪɚɡ ɜ 7 ɞɧɟɣ |
|
|
|
ɤɚɧ», «Ɏɥɸɤɨɫɬɚɬ») |
|
|
|
|
|
|
|
ɢ ɜɧɭɬɪɶ |
0,15 ɝ |
0,15 ɝ |
ɜɧɭɬɪɶ |
1 ɪɚɡ ɜ 7 ɞɧɟɣ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɇɢɫɬɚɬɢɧ |
500 000 ȿȾ |
2 000 000– |
ɜɧɭɬɪɶ |
5–7 ɫɭɬ |
|
|
|
|
|
3 000 000 |
|
|
ɇɚɩɪɚɜɥɟɧɚ ɧɚ ɭɫɬɪɚ- |
|
|
|
|
ȿȾ |
|
|
ɧɟɧɢɟ ɝɢɩɨɜɨɥɟɦɢɢ; |
|
|
|
|
|
|
|
ɪɚɫɫɬɪɨɣɫɬɜ ɫɟɪɞɟɱ- |
|
|
ɂɇɎɍɁɂɈɇɇɈ-ɌɊȺɇɋɎɍɁɂɈɇɇȺə ɌȿɊȺɉɂə |
|
|
|||
|
|
|
|
|
|
ɧɨɣ ɞɟɹɬɟɥɶɧɨɫɬɢ; ɧɚ- |
|
|
Ⱦɟɤɫɬɪɚɧ [ɫɪɟɞɧɹɹ ɦɨɥɟɤɭ- |
400 ɦɥ |
400 ɦɥ |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
2–3 ɫɭɬ |
||
|
ɥɹɪɧɚɹ ɦɚɫɫɚ 30 000– |
|
|
|
|
ɪɭɲɟɧɢɣ ɝɟɦɨɞɢɧɚ- |
|
|
40 000] («Ɋɟɨɩɨɥɢɝɥɸ- |
|
|
|
|
ɦɢɤɢ; ɤɨɪɪɟɥɹɰɢɸ ɧɚ- |
|
|
ɤɢɧ») ɪ-ɪ |
|
|
|
|
ɪɭɲɟɧɢɣ ɜɨɞɧɨ- |
|
|
ɢɥɢ |
|
|
|
|
ɷɥɟɤɬɪɨɥɢɬɧɨɝɨ ɢ ɤɢ- |
|
|
ɉɨɜɢɞɨɧ 8000+ɧɚɬɪɢɹ |
200–400 ɦɥ |
200–400 |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
2–3 ɫɭɬ |
ɫɥɨɬɧɨ-ɨɫɧɨɜɧɨɝɨ ɫɨ- |
|
|
ɯɥɨɪɢɞ+ɤɚɥɢɹ ɯɥɨ- |
|
ɦɥ |
|
|
ɫɬɨɹɧɢɹ, ɝɟɦɨɫɬɚɡɚ, |
|
|
ɪɢɞ+ɤɚɥɶɰɢɹ ɯɥɨ- |
|
|
|
|
ɭɫɬɪɚɧɟɧɢɟ ɚɧɟɦɢɢ, |
|
|
ɪɢɞ+ɦɚɝɧɢɹ ɯɥɨ- |
|
|
|
|
ɝɢɩɨɩɪɨɬɟɢɧɟɦɢɢ ɢ |
|
|
ɪɢɞ+ɧɚɬɪɢɹ ɝɢɞɪɨɤɚɪɛɨɧɚɬ |
|
|
|
|
ɞɪ. |
|
|
(«Ƚɟɦɨɞɟɡ-ɇ») |
|
|
|
|
ɉɪɨɞɨɥɠɢɬɟɥɶɧɨɫɬɶ, |
|
|
ɢɥɢ |
|
|
|
|
||
|
|
|
|
|
|
|
|
167 ...заболеваний инфекционных терапии при применяемые ЛС,
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
Ⱦɟɤɫɬɪɚɧ [ɫɪɟɞɧɹɹ ɦɨɥɟɤɭ- |
400 ɦɥ |
400 ɦɥ |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
2–3 ɫɭɬ |
ɨɛɴɟɦ ɢ ɫɨɫɬɚɜ ɢɧɮɭ- |
|
|
ɥɹɪɧɚɹ ɦɚɫɫɚ 50 000– |
|
|
|
|
ɡɢɨɧɧɨɣ ɬɟɪɚɩɢɢ ɡɚ- |
|
|
70 000] (ɩɨɥɢɝɥɸɤɢɧ) ɪ-ɪ |
|
|
|
|
ɜɢɫɹɬ ɨɬ ɫɬɟɩɟɧɢ ɬɹ- |
|
|
ɢɥɢ |
|
|
|
|
ɠɟɫɬɢ ɡɚɛɨɥɟɜɚɧɢɹ |
|
|
ɏɥɨɪɢɞ ɧɚɬɪɢɹ 0,9% ɪ-ɪ |
400 ɦɥ |
400–800 ɦɥ |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
3–4 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ƚɢɞɪɨɤɫɢɷɬɢɥɤɪɚɯɦɚɥ 6– |
250–500 ɦɥ |
500 ɦɥ |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
2–3 ɫɭɬ |
|
|
|
10% ɪ-ɪ («Ɋɟɮɨɪɬɚɧ ȽɗɄ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ⱥɥɶɛɭɦɢɧ 10% ɪ-ɪ |
100 ɦɥ |
100–200 ɦɥ |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
3–4 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ⱦɟɤɫɬɪɨɡɚ 5% ɪ-ɪ |
400 ɦɥ |
400–800 ɦɥ |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
3–4 ɫɭɬ |
|
|
|
|
|
|
|
|
|
|
|
ȺɇȿɋɌȿɁɂɈɅɈȽɂɑȿɋɄɈȿ |
ɉɈɋɈȻɂȿ |
ɉɊɂ ɆȺɅɕɏ ɈɉȿɊȺɐɂəɏ |
ɉɪɢ ɜɚɤɭɭɦ- |
|||
|
ȼɧɭɬɪɢɜɟɧɧɵɣ ɧɚɪɤɨɡ |
|
|
|
|
ɚɫɩɢɪɚɰɢɢ, ɜɵɫɤɚɛɥɢ- |
|
|
|
|
|
|
|
|
ɜɚɧɢɢ ɦɚɬɤɢ |
|
|
Ʉɟɬɚɦɢɧ |
|
2–4,5 ɦɝ/ɤɝ |
ɜ/ɜ |
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɉɪɨɩɨɮɨɥ («Ⱦɢɩɪɢ- |
|
1,5–2,5 |
ɜ/ɜ |
|
|
|
|
ɜɚɧ») |
|
ɦɝ/ɤɝ |
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ɍɢɨɩɟɧɬɚɥ ɧɚɬɪɢɹ |
|
3–10 ɦɝ/ɤɝ |
ɜ/ɜ |
|
|
|
|
ȺɇȿɋɌȿɁɂɈɅɈȽɂɑɋȿɄɈȿ |
ɉɈɋɈȻɂȿ |
ɉɊɂ ȻɈɅɖɒɂɏ ɈɉȿɊȺɐɂəɏ |
|
||
|
(ɷɤɫɬɢɪɩɚɰɢɹ ɦɚɬɤɢ), ɫɦ. ɪɚɡɞɟɥ «Ⱥɧɟɫɬɟɡɢɨɥɨɝɢɹ» |
|
|
|
|||
|
ȺɇɌɂɄɈȺȽɍɅəɇɌɕ ɂ ȾȿɁȺȽɊȿȽȺɇɌɕ |
|
|
ɉɪɨɮɢɥɚɤɬɢɤɚ ɬɪɨɦ- |
|||
|
|
Ⱦɟɤɫɬɪɚɧ [ɫɪɟɞɧɹɹ ɦɨ- |
400 ɦɥ |
400 ɦɥ |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
1–2 ɫɭɬ |
ɛɨɬɢɱɟɫɤɢɯ ɨɫɥɨɠɧɟ- |
|
|
ɥɟɤɭɥɹɪɧɚɹ ɦɚɫɫɚ |
|
|
|
|
ɧɢɣ ɩɨɞ ɤɨɧɬɪɨɥɟɦ |
|
|
|
|
|
|
|
|
168
6 Раздел
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
|
30 000–40 000] («Ɋɟɨ- |
|
|
|
|
ɩɨɤɚɡɚɬɟɥɟɣ ɝɟɦɨɫɬɚɡɚ |
|
|
ɩɨɥɢɝɥɸɤɢɧ») ɪ-ɪ |
|
|
|
|
|
|
+ |
|
|
|
|
|
|
|
|
Ƚɟɩɚɪɢɧ ɧɚɬɪɢɹ |
5000 ȿȾ |
10 000– |
ɩ/ɤ |
5 ɫɭɬ |
|
|
|
|
|
15 000 ȿȾ |
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ⱦɚɥɬɟɩɚɪɢɧ ɧɚɬɪɢɹ |
0,3 ɦɥ |
0,3–0,6 ɦɥ |
ɩ/ɤ |
5 ɫɭɬ |
|
|
|
(«Ɏɪɚɝɦɢɧ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɇɚɞɪɨɩɚɪɢɧ ɤɚɥɶɰɢɹ |
0,3 ɦɥ |
0,3–0,6 ɦɥ |
ɩ/ɤ |
5 ɫɭɬ |
|
|
|
(«Ɏɪɚɤɫɢɩɚɪɢɧ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɗɧɨɤɫɚɩɚɪɢɧ ɧɚɬɪɢɹ |
0,2 ɦɥ |
0,2 ɦɥ |
ɩ/ɤ |
5 ɫɭɬ |
|
|
|
(«Ʉɥɟɤɫɚɧ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ⱦɢɩɢɪɢɞɚɦɨɥ («Ʉɭɪɚɧ- |
0,025 ɝ |
0,075 ɝ |
ɜɧɭɬɪɶ |
5 ɫɭɬ |
|
|
|
ɬɢɥ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɉɟɧɬɨɤɫɢɮɢɥɥɢɧ |
0,4 ɝ |
0,8 ɝ |
ɜɧɭɬɪɶ |
5 ɫɭɬ |
|
|
|
(«Ⱥɝɚɩɭɪɢɧ ɪɟɬɚɪɞ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ⱥɰɟɬɢɥɫɚɥɢɰɢɥɨɜɚɹ ɤɢ- |
0,05–0,1 ɝ |
0,05–0,1 ɝ |
ɜɧɭɬɪɶ |
5 ɫɭɬ |
|
|
|
ɫɥɨɬɚ («Ɍɪɨɦɛɨ Ⱥɋɋ») |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ȾȿɋȿɇɋɂȻɂɅɂɁɂɊɍɘɓȺə |
ɌȿɊȺɉɂə |
|
|
|
ɇɚɡɧɚɱɚɸɬ ɞɟɫɟɧɫɢ- |
|
|
Ⱦɢɮɟɧɝɢɞɪɚɦɢɧ («Ⱦɢ- |
1 ɦɥ |
2–3 ɦɥ |
ɜ/ɦ |
10–12 ɫɭɬ |
ɛɢɥɢɡɢɪɭɸɳɢɟ Ʌɋ — |
|
|
ɦɟɞɪɨɥ») 1% ɪ-ɪ |
|
|
|
|
ɛɥɨɤɚɬɨɪɵ ɇ2- |
169 ...заболеваний инфекционных терапии при применяемые ЛС,
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
|
ɢɥɢ ɜɧɭɬɪɶ |
0,05 ɝ |
0,1 ɝ |
ɜɧɭɬɪɶ |
10–12 ɫɭɬ |
ɪɟɰɟɩɬɨɪɨɜ ɝɢɫɬɚɦɢɧɚ |
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɉɪɨɦɟɬɚɡɢɧ («Ⱦɢɩɪɚ- |
2 ɦɥ |
4 ɦɥ |
ɜ/ɦ |
10–12 ɫɭɬ |
|
|
|
ɡɢɧ», «ɉɢɩɨɥɶɮɟɧ») |
|
|
|
|
|
|
|
2,5% ɪ-ɪ ɢɥɢ ɜɧɭɬɪɶ |
0,025 ɝ |
0,05 ɝ |
ɜɧɭɬɪɶ |
10–12 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɏɥɨɪɨɩɢɪɚɦɢɧ («ɋɭɩ- |
1 ɦɥ |
2 ɦɥ |
ɜ/ɦ |
10–12 ɫɭɬ |
|
|
|
ɪɚɫɬɢɧ») 2% ɪ-ɪ |
|
|
|
|
|
|
|
ɢɥɢ ɜɧɭɬɪɶ |
0,025 ɝ |
0,05 ɝ |
ɜɧɭɬɪɶ |
10–12 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ɇɟɛɝɢɞɪɨɥɢɧ («Ⱦɢɚɡɨ- |
0,1 ɝ |
0,2–0,3 ɝ |
ɜɧɭɬɪɶ |
10–12 ɫɭɬ |
|
|
|
ɥɢɧ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ʉɟɬɨɬɢɮɟɧ |
0,001 ɝ |
0,002 ɝ |
ɜɧɭɬɪɶ |
10–12 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɏɢɮɟɧɚɞɢɧ («Ɏɟɧɤɚ- |
0,025 ɝ |
0,05– |
ɜɧɭɬɪɶ |
10–12 ɫɭɬ |
|
|
|
ɪɨɥ») |
|
0,075 ɝ |
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ʌɨɪɚɬɚɞɢɧ («Ʉɥɚɪɢ- |
0,01 ɝ |
0,01 ɝ |
ɜɧɭɬɪɶ |
10–12 ɫɭɬ |
|
|
|
ɬɢɧ») |
|
|
|
|
|
|
|
ɄɈɊɊȿɄɐɂə ɇȺɊɍɒȿɇɂɃ |
ɂɆɆɍɇɇɈȽɈ ɂ ɂɇɌȿɊɎȿɊɈɇɈȼɈȽɈ ɋɌȺɌɍɋȺ |
|
|||
|
|
ɂɦɦɭɧɨɝɥɨɛɭɥɢɧ ɱɟɥɨ- |
0,25–0,5 ɝ/ɤɝ |
0,25– |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
3 ɜɜɟɞɟɧɢɹ ɱɟɪɟɡ |
|
|
|
ɜɟɤɚ ɧɨɪɦɚɥɶɧɵɣ ɞɥɹ |
|
0,5 ɝ/ɤɝ |
|
ɫɭɬ |
|
|
|
ɜɧɭɬɪɢɜɟɧɧɨɝɨ ɜɜɟɞɟ- |
|
|
|
|
|
|
|
ɧɢɹ, ɠɢɞɤɢɣ |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
|
|
|
|
|
170
6 Раздел
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
|
ɂɧɬɟɪɮɟɪɨɧ ɚɥɶɮɚ-2 |
1 000 000 Ɇȿ |
2 000 000 |
Ɋɟɤɬɚɥɶɧɵɟ |
10 ɫɭɬ |
|
|
|
(«ȼɢɮɟɪɨɧ», «Ƚɟɧɮɟ- |
|
Ɇȿ |
ɫɜɟɱɢ |
|
|
|
|
ɪɨɧ», «Ʉɢɩɮɟɪɨɧ») |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ɂɦɦɭɧɨɦɨɞɭɥɹɬɨɪɵ |
|
|
|
|
|
|
|
Ⱥɪɝɟɧɢɥ-ɚɥɶɮɚ- |
1 ɦɥ |
1 ɦɥ |
ɜ/ɦ |
5–10 ɫɭɬ |
|
|
|
ɚɫɩɚɪɬɢɥ-ɥɢɡɢɥ-ɜɚɥɢɥ- |
|
|
|
|
|
|
|
ɬɢɪɨɡɢɥ-ɚɪɝɟɧɢɧ |
|
|
|
|
|
|
|
(«ɂɦɭɧɨɮɚɧ») 0,005% |
|
|
|
|
|
|
|
ɪ-ɪ |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
«Ʌɢɤɨɩɢɞ» |
0,001 ɝ |
0,002– |
ɉɨɞ ɹɡɵɤ |
10 ɫɭɬ |
|
|
|
|
0,01 ɝ |
0,003 ɝ |
ɜɧɭɬɪɶ |
|
|
|
|
ɢɥɢ |
|
0,2–0,3 ɝ |
|
|
|
|
|
ɇɚɬɪɢɹ ɪɢɛɨɧɭɤɥɟɚɬ |
0,5 ɦɥ |
0,5–1 ɦɥ |
ɜ/ɦ |
5 ɢɧɴɟɤɰɢɣ ɱɟɪɟɡ |
|
|
|
(«Ɋɢɞɨɫɬɢɧ») |
|
|
|
ɞɟɧɶ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ɇɟɝɥɭɦɢɧɚ ɚɤɪɢɞɨɧ- |
0,25 ɝ |
0,25 ɝ |
ɜ/ɦ |
5 ɢɧɴɟɤɰɢɣ ɱɟɪɟɡ |
|
|
|
ɚɰɟɬɚɬ («ɐɢɤɥɨɮɟɪɨɧ») |
|
|
|
ɞɟɧɶ |
|
|
|
ȽɅɘɄɈɄɈɊɌɂɄɈɂȾɕ |
|
|
|
|
ɉɪɢ ɝɢɩɨɬɟɧɡɢɢ |
|
|
ɉɪɟɞɧɢɡɨɥɨɧ |
0,03 ɝ |
0,03–0,09 ɝ |
ɜ/ɜ |
1–2 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ƚɢɞɪɨɤɨɪɬɢɡɨɧ |
0,1–0,5 ɝ |
0,5–0,75 ɝ |
ɜ/ɜ |
1–2 ɫɭɬ |
|
|
|
ɗɍȻɂɈɌɂɄɂ: |
|
|
|
|
|
|
Ȼɢɮɢɞɭɦɛɚɤɬɟɪɢɢ, ɥɢɨɮɢɥɢɡɢɪɨɜɚɧɧɵɟ ɛɚɤɬɟɪɢɢ Lactobacillus acidophilus, Bifidobacterium |
|
|||||
|
infantis v. liberorum, Streptococcus faecium ɢ ɞɪ. |
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
Ȼɢɮɢɞɨɛɚɤɬɟɪɢɢɛɢɮɢɞɭɦ |
5 ɞɨɡ |
15 ɞɨɡ |
ɜɧɭɬɪɶ |
10–12 ɫɭɬ |
|
171 ...заболеваний инфекционных терапии при применяемые ЛС,